XBI Holdings Information

XBI is an equity ETF with a total of 136 individual holdings. The top holdings are CRISPR Therapeutics AG stock at 2.28%, AbbVie at 2.08%, Moderna at 2.04%, United Therapeutics at 1.99%, and Exelixis at 1.97%.

Total Holdings

136

Top 10 Percentage

19.92%

Asset Class

Equity

ETF Category

Health

Assets

5.67B

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	CRSP	CRISPR Therapeutics AG	2.28%	2,088,294
2	ABBV	AbbVie Inc.	2.08%	514,631
3	MRNA	Moderna, Inc.	2.04%	4,481,617
4	UTHR	United Therapeutics Corporation	1.99%	274,792
5	EXEL	Exelixis, Inc.	1.97%	2,889,921
6	BIIB	Biogen Inc.	1.95%	763,992
7	REGN	Regeneron Pharmaceuticals, Inc.	1.94%	196,024
8	AMGN	Amgen Inc.	1.93%	391,213
9	MDGL	Madrigal Pharmaceuticals, Inc.	1.88%	253,318
10	VRTX	Vertex Pharmaceuticals Incorporated	1.87%	280,419
11	EXAS	Exact Sciences Corporation	1.85%	1,989,240
12	IONS	Ionis Pharmaceuticals, Inc.	1.85%	1,702,377
13	RVMD	Revolution Medicines, Inc.	1.84%	2,434,099
14	BBIO	BridgeBio Pharma, Inc.	1.82%	2,057,227
15	INSM	Insmed Incorporated	1.82%	746,669
16	BMRN	BioMarin Pharmaceutical Inc.	1.81%	1,999,049
17	INCY	Incyte Corporation	1.81%	1,263,238
18	HALO	Halozyme Therapeutics, Inc.	1.78%	1,437,332
19	ALNY	Alnylam Pharmaceuticals, Inc.	1.77%	232,098
20	NBIX	Neurocrine Biosciences, Inc.	1.74%	771,345
21	GILD	Gilead Sciences, Inc.	1.73%	945,389
22	TGTX	TG Therapeutics, Inc.	1.73%	2,870,188
23	NTRA	Natera, Inc.	1.71%	641,691
24	RNA	Avidity Biosciences, Inc.	1.67%	2,348,111
25	ROIV	Roivant Sciences Ltd.	1.65%	6,340,544

Showing 25 of 136 holdings

Subscribe to see the full list

Upgrade Now

As of Oct 1, 2025